spacer.png, 0 kB
Home arrow Ghostwriting guidelines
Ghostwriting Guidelines | Print |

NEW EMWA POSITION STATEMENT AND GUIDELINES

EMWA is pleased to announce that its position statement and guidelines on the role of medical writers in developing peer-reviewed publications have now been published by Current Medical Research and Opinion (CMRO). Please click here to read these guidelines. In the same issue of CMRO, the EMWA Ghostwriting Task Force has also published the findings of a Delphi consultation process designed to explore the current problems of ghostwriting in medical publications. Please click here to read this report.

At the EMWA conference in Malta, Adam Jacobs presented a plenary lecture on the new EMWA guidelines on the role of medical writers in developing peer-reviewed publications. This presentation provided an overview the issue of ghostwriting, the processes involved in developing the EMWA guidelines, and the recommendations of these guidelines. For those of you who missed this talk, please click here to download the PowerPoint presentation. Adam has also published an article on Ghostwriting in EMWA's TWS. To read this article, please click here.

In a recent issue of FastTrack, a newsletter from Current Medical Research and Opinion (CMRO), EMWA members, Adam Jacobs and Liz Wager, have both contributed articles of particular reevance to medical writers. Adam's contribution is an article titled, "Professional Medical Writers and Medical Publications: The Importance of Ethical Guidelines". This article tackles the issue of ethical medical writing and the new EMWA guidelines. Liz Wager's article, entitled, "Vancouver Group’ Journals Will Require Trial Registration from 2005", alerts the reader to the recent announcement by the Vancouver Group of journals (i.e. The Lancet, JAMA, New England Journal of Medicine, Annals of Internal Medicine, and the BMJ) that, in order for a trial to be published, it must have been registered.
 
spacer.png, 0 kB